Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment

Marine Drugs

Volumn 9, Issue 9, 2011, Pages 1580-1606

  Essack, Magbubah ^a   Bajic, Vladimir B ^a   Archer, John A C ^a  

^a KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

Author keywords

Anticancer; Apoptosis; Cancer treatment; Marine sponge; Targeted cancer therapy

Indexed keywords

13E,17E GLOBOSTELLATIC ACID X METHYL ESTER; 5ALPHA,6ALPHA EPOXY PETROSTEROL; CANDIDASPONGIOLIDE; DEATH RECEPTOR; DEATH RECEPTOR TYPE I; DEATH RECEPTOR TYPE II; GEODITIN A; GEODITIN B; IRCINIASTATIN A; JASPOLIDE B; KUANONIAMINE A; KUANONIAMINE C; LEAD; MONANCHOCIDIN; NAAMIDINE A; NATURAL PRODUCT; PACHASTRISSAMINE; PETROSTEROL 3,6 DIONE; PSAMMAPLYSENE A; RENIERAMYCIN M; RHABDASTRELLIC ACID A; RHIZOCHALIN; SALARIN C; SIPHOLENOL A; SMENOSPONGINE; SODWANONE V; SPONGISTATIN 1; STELLETTIN A; STELLETTIN B; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL DESTRUCTION; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; MARINE SPECIES; MITOCHONDRIAL MEMBRANE; MOLECULARLY TARGETED THERAPY; NONHUMAN; REVIEW; SPONGE (PORIFERA);

EID: 80053301623     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md9091580     Document Type: Review

References (136)

1. Kawabe, T. G2 checkpoint abrogators as anticancer drugs. Mol. Cancer Ther. 2004, 3, 513-519.
2. Maione, P.; Rossi, A.; Airoma, G.; Ferrara, C.; Castaldo, V.; Gridelli, C. The role of targeted therapy in non-small cell lung cancer. Crit. Rev. Oncol. Hematol. 2004, 51, 29-44. (Pubitemid 38781749)
3. Rossi, D.; Gaidano, G. Messengers of cell death: apoptotic signaling in health and disease. Haematologica 2003, 88, 212-218. (Pubitemid 37101499)
4. Belarbi el, H.; Contreras Gomez, A.; Chisti, Y.; Garcia Camacho, F.; Molina Grima, E. Producing drugs from marine sponges. Biotechnol. Adv. 2003, 21, 585-598.
5. Wehrl, M.; Steinert, M.; Hentschel, U. Bacterial uptake by the marine sponge Aplysina aerophoba. Microb. Ecol. 2007, 53, 355-365.
6. Vacelet, J.; Duport, E. Prey capture and digestion in the carnivorous sponge Asbestopluma hypogea (Porifera: Demospongiae). Zoomorphology 2004, 123, 179-190. (Pubitemid 40047495)
7. Sokolover, N.; Ilan, M. Assessing anti-predatory chemical defences among ten eastern Mediterranean sponges. J. Mar. Biol. Assoc. UK 2007, 87, 1785-1790. (Pubitemid 350211195)
8. Peters, K.J.; Amsler, C.D.; McClintock, J.B.; Baker, B.J. Potential chemical defenses of Antarctic sponges against sympatric microorganisms. Polar Biolol. 2010, 33, 649-658.
9. Chaves-Fonnegra, A.; Castellanos, L.; Zea, S.; Duque, C.; Rodriguez, J.; Jimenez, C. Clionapyrrolidine A - a metabolite from the encrusting and excavating sponge Cliona tenuis that kills coral tissue upon contact. J. Chem. Ecol. 2008, 34, 1565-1574.
10. Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2011, 28, 196-268.
11. Joseph, B.; Sujatha, S. Pharmacologically Important Natural products from Marine Sponges. J. Nat. Prod. 2011, 4, 5-12.
12. Thomas, T.R.; Kavlekar, D.P.; LokaBharathi, P.A. Marine drugs from sponge-microbe association - a review. Mar. Drugs 2010, 8, 1417-1468.
13. Bergmann, W.; Feeney, R.J. The isolation of a new thymine pentoside from sponges. J. Am. Chem. Soc. 1950, 72, 2809-2810.
14. Bergmann, W.; Feeney, R.J. Contributions to the study of marine products. XXXII. The nucleosides of sponges. I. J. Org. Chem. 1951, 16, 981-987.
15. Proksch, P.; Edrada, R.A.; Ebel, R. Drugs from the seas - current status and microbiological implications. Appl. Microbiol. Biotechnol. 2002, 59, 125-134. (Pubitemid 34756951)
16. Schwartsmann, G. Marine organisms and other novel natural sources of new cancer drugs. Ann. Oncol. 2000, 11 (Suppl. 3), 235-243.
17. Feldman, E.J.; Lancet, J.E.; Kolitz, J.E.; Ritchie, E.K.; Roboz, G.J.; List, A.F.; Allen, S.L.; Asatiani, E.; Mayer, L.D.; Swenson, C.; Louie, A.C. First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia. J. Clin. Oncol. 2011, 29, 979-985.
18. Agura, E.; Cooper, B.; Holmes, H.; Vance, E.; Berryman, R.B.; Maisel, C.; Li, S.; Saracino, G.; Tadic-Ovcina, M.; Fay, J. Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity. Oncologist 2011, 16, 197-206.
19. Walker, A.R.; Komrokji, R.S.; Ifthikharuddin, J.; Messina, P.; Mulford, D.; Becker, M.; Friedberg, J.; Oliva, J.; Phillips, G.; Liesveld, J.L.; Abboud, C. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML. Leuk. Res. 2008, 32, 1830-1836.
20. Sipkema, D.; Osinga, R.; Schatton, W.; Mendola, D.; Tramper, J.; Wijffels, R.H. Large-scale production of pharmaceuticals by marine sponges: sea, cell, or synthesis? Biotechnol. Bioeng. 2005, 90, 201-222. (Pubitemid 40571480)
21. Madajewicz, S.; Zojwalla, N.J.; Lucarelli, A.G.; Hentschel, P.; Giardelli, J.; Schuck, E.L.; Krivelevich, I.; Wong, B.Y.; Vogelzang, N.J.; Sharma, S. A phase I trial of E7974 administered on days 1 and 15 of a 28-day cycle in patients with solid malignancies. J. Clin. Oncol. 2007, 25, 2550.
22. Yanagimoto, H.; Shiomi, H.; Satoi, S.; Mine, T.; Toyokawa, H.; Yamamoto, T.; Tani, T.; Yamada, A.; Kwon, A.H.; Komatsu, N.; Itoh, K.; Noguchi, M. A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patients. Oncol. Rep. 2010, 24, 795-801.
23. Twelves, C.; Cortes, J.; Vahdat, L.T.; Wanders, J.; Akerele, C.; Kaufman, P.A. Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer. Clin. Breast Cancer 2010, 10, 160-163.
24. Newman, D.J.; Cragg, G.M. Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod. 2004, 67, 1216-1238. (Pubitemid 39145623)
25. Sayers, E.W.; Barrett, T.; Benson, D.A.; Bolton, E.; Bryant, S.H.; Canese, K.; Chetvernin, V.; Church, D.M.; DiCuccio, M.; Federhen, S.; et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2011, 39, D38-D51.
26. Shubina, L.K.; Makarieva, T.N.; Dyshlovoy, S.A.; Fedorov, S.N.; Dmitrenok, P.S.; Stonik, V.A. Three new aaptamines from the marine sponge Aaptos sp. and their proapoptotic properties. Nat. Prod. Commun. 2010, 5, 1881-1884.
27. Kijjoa, A.; Wattanadilok, R.; Campos, N.; Nascimento, M.S.; Pinto, M.; Herz, W. Anticancer activity evaluation of kuanoniamines A and C isolated from the marine sponge Oceanapia sagittaria, collected from the Gulf of Thailand. Mar. Drugs 2007, 5, 6-22. (Pubitemid 46998586)
28. Whibley, C.E.; Keyzers, R.A.; Soper, A.G.; Davies-Coleman, M.T.; Samaai, T.; Hendricks, D.T. Antiesophageal cancer activity from Southern African marine organisms. Ann. N. Y. Acad. Sci. 2005, 1056, 405-412. (Pubitemid 43030995)
29. Guzii, A.G.; Makarieva, T.N.; Denisenko, V.A.; Dmitrenok, P.S.; Kuzmich, A.S.; Dyshlovoy, S.A.; Krasokhin, V.B.; Stonik, V.A. Monanchocidin: a new apoptosis-inducing polycyclic guanidine alkaloid from the marine sponge Monanchora pulchra. Org. Lett. 2010, 12, 4292-4295.
30. LaBarbera, D.V.; Modzelewska, K.; Glazar, A.I.; Gray, P.D.; Kaur, M.; Liu, T.; Grossman, D.; Harper, M.K.; Kuwada, S.K.; Moghal, N.; Ireland, C.M. The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells. Anticancer Drugs 2009, 20, 425-436.
31. Berry, E.; Hardt, J.L.; Clardy, J.; Lurain, J.R.; Kim, J.J. Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1. Gynecol. Oncol. 2009, 112, 331-336.
32. Halim, H.; Chunhacha, P.; Suwanborirux, K.; Chanvorachote, P. Anticancer and Antimetastatic Activities of Renieramycin M, a Marine Tetrahydroisoquinoline Alkaloid, in Human Non-small Cell Lung Cancer Cells. Anticancer Res. 2011, 31, 193-201.
33. Aoki, S.; Cho, S.H.; Ono, M.; Kuwano, T.; Nakao, S.; Kuwano, M.; Nakagawa, S.; Gao, J.Q.; Mayumi, T.; Shibuya, M.; Kobayashi, M. Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells. Anticancer Drugs 2006, 17, 269-278.
34. Park, C.; Kim, G.Y.; Kim, W.I.; Hong, S.H.; Park, D.I.; Kim, N.D.; Bae, S.J.; Jung, J.H.; Choi, Y.H. Induction of apoptosis by (Z)-stellettic acid C, an acetylenic acid from the sponge Stelletta sp., is associated with inhibition of telomerase activity in human leukemic U937 cells. Chemotherapy 2007, 53, 160-168. (Pubitemid 46581987)
35. Tung, N.H.; Van Minh, C.; Ha, T.T.; Van Kiem, P.; Huong, H.T.; Dat, N.T.; Nhiem, N.X.; Tai, B.H.; Hyun, J.H.; Kang, H.K.; Kim, Y.H. C29 sterols with a cyclopropane ring at C-25 and 26 from the Vietnamese marine sponge Ianthella sp. and their anticancer properties. Bioorg. Med. Chem. Lett. 2009, 19, 4584-4588.
36. Umeyama, A.; Matsuoka, N.; Mine, R.; Nakata, A.; Arimoto, E.; Matsui, M.; Shoji, N.; Arihara, S.; Takei, M.; Hashimoto, T. Polyacetylene diols with antiproliferative and driving Th1 polarization effects from the marine sponge Callyspongia sp. J. Nat. Med. 2010, 64, 93-97.
37. Salma, Y.; Lafont, E.; Therville, N.; Carpentier, S.; Bonnafe, M.J.; Levade, T.; Genisson, Y.; Andrieu-Abadie, N. The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism. Biochem. Pharmacol. 2009, 78, 477-485.
38. + Cl41 cells. Lipids 2009, 44, 777-785.
39. Trisciuoglio, D.; Uranchimeg, B.; Cardellina, J.H.; Meragelman, T.L.; Matsunaga, S.; Fusetani, N.; Del Bufalo, D.; Shoemaker, R.H.; Melillo, G. Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide. J. Natl. Cancer Inst. 2008, 100, 1233-1246.
40. Chinen, T.; Nagumo, Y.; Watanabe, T.; Imaizumi, T.; Shibuya, M.; Kataoka, T.; Kanoh, N.; Iwabuchi, Y.; Usui, T. Irciniastatin A induces JNK activation that is involved in caspase-8-dependent apoptosis via the mitochondrial pathway. Toxicol. Lett. 2010, 199, 341-346.
41. Konishi, H.; Kikuchi, S.; Ochiai, T.; Ikoma, H.; Kubota, T.; Ichikawa, D.; Fujiwara, H.; Okamoto, K.; Sakakura, C.; Sonoyama, T.; Kokuba, Y.; Sasaki, H.; Matsui, T.; Otsuji, E. Latrunculin a has a strong anticancer effect in a peritoneal dissemination model of human gastric cancer in mice. Anticancer Res. 2009, 29, 2091-2097.
42. Ben-Califa, N.; Bishara, A.; Kashman, Y.; Neumann, D. Salarin C, a member of the salarin superfamily of marine compounds, is a potent inducer of apoptosis. Invest. New Drugs 2010, doi:10.1007/s10637-010-9521-4.
43. Schyschka, L.; Rudy, A.; Jeremias, I.; Barth, N.; Pettit, G.R.; Vollmar, A.M. Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP. Leukemia 2008, 22, 1737-1745.
44. Aoki, S.; Sanagawa, M.; Watanabe, Y.; Setiawan, A.; Arai, M.; Kobayashi, M. Novel isomarabarican triterpenes, exhibiting selective anti-proliferative activity against vascular endothelial cells, from marine sponge Rhabdastrella globostellata. Bioorg. Med. Chem. 2007, 15, 4818-4828. (Pubitemid 46839237)
45. Dai, J.; Fishback, J.A.; Zhou, Y.D.; Nagle, D.G. Sodwanone and yardenone triterpenes from a South African species of the marine sponge Axinella inhibit hypoxia-inducible factor-1 (HIF-1) activation in both breast and prostate tumor cells. J. Nat. Prod. 2006, 69, 1715-1720.
46. Liu, W.K.; Ho, J.C.; Che, C.T. Apoptotic activity of isomalabaricane triterpenes on human promyelocytic leukemia HL60 cells. Cancer Lett. 2005, 230, 102-110. (Pubitemid 41506965)
47. Cheung, F.W.; Li, C.; Che, C.T.; Liu, B.P.; Wang, L.; Liu, W.K. Geoditin A induces oxidative stress and apoptosis on human colon HT29 cells. Mar. Drugs 2010, 8, 80-90.
48. Schumacher, M.; Cerella, C.; Eifes, S.; Chateauvieux, S.; Morceau, F.; Jaspars, M.; Dicato, M.; Diederich, M. Heteronemin, a spongean sesterterpene, inhibits TNF alpha-induced NF-kappa B activation through proteasome inhibition and induces apoptotic cell death. Biochem. Pharmacol. 2010, 79, 610-622.
49. Lu, P.H.; Chueh, S.C.; Kung, F.L.; Pan, S.L.; Shen, Y.C.; Guh, J.H. Ilimaquinone, a marine sponge metabolite, displays anticancer activity via GADD153-mediated pathway. Eur. J. Pharmacol. 2007, 556, 45-54.
50. Wei, S.Y.; Li, M.; Tang, S.A.; Sun, W.; Xu, B.; Cui, J.R.; Lin, W.H. Induction of apoptosis accompanying with G(1) phase arrest and microtubule disassembly in human hepatoma cells by jaspolide B, a new isomalabaricane-type triterpene. Cancer Lett. 2008, 262, 114-122.
51. Guo, J.F.; Zhou, J.M.; Feng, G.K.; Liu, Z.C.; Xiao, D.J.; Deng, S.Z.; Deng, R.; Zhu, X.F. Apoptosis of human leukemia HL-60 cells induced by rhabdastrellic acid-A and its mechanisms. Ai Zheng 2007, 26, 809-814 (in Chinese).
52. Shi, Z.; Jain, S.; Kim, I.W.; Peng, X.X.; Abraham, I.; Youssef, D.T.; Fu, L.W.; El Sayed, K.; Ambudkar, S.V.; Chen, Z.S. Sipholenol A, a marine-derived sipholane triterpene, potently reverses P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Cancer Sci. 2007, 98, 1373-1380.
53. Kong, D.; Aoki, S.; Sowa, Y.; Sakai, T.; Kobayashi, M. Smenospongine, a sesquiterpene aminoquinone from a marine sponge, induces G1 arrest or apoptosis in different leukemia cells. Mar. Drugs 2008, 6, 480-488.
54. Peter, M.E.; Krammer, P.H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003, 10, 26-35. (Pubitemid 36511830)
55. Lin, F.L.; Hsu, J.L.; Chou, C.H.; Wu, W.J.; Chang, C.I.; Liu, H.J. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-alpha and p53 pathways. Eur. J. Pharmacol. 2011, 650, 120-129.
56. Singh, A.; Ni, J.; Aggarwal, B.B. Death domain receptors and their role in cell demise. J. Interferon Cytokine Res. 1998, 18, 439-450. (Pubitemid 28363570)
57. Merino, D.; Lalaoui, N.; Morizot, A.; Schneider, P.; Solary, E.; Micheau, O. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol. Cell. Biol. 2006, 26, 7046-7055. (Pubitemid 44477684)
58. Bodmer, J.L.; Holler, N.; Reynard, S.; Vinciguerra, P.; Schneider, P.; Juo, P.; Blenis, J.; Tschopp, J. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat. Cell Biol. 2000, 2, 241-243.
59. Scaffidi, C.; Fulda, S.; Srinivasan, A.; Friesen, C.; Li, F.; Tomaselli, K.J.; Debatin, K.M.; Krammer, P.H.; Peter, M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998, 17, 1675-1687. (Pubitemid 28119121)
60. Belizario, J.E.; Alves, J.; Occhiucci, J.M.; Garay-Malpartida, M.; Sesso, A. A mechanistic view of mitochondrial death decision pores. Braz. J. Med. Biol. Res. 2007, 40, 1011-1024. (Pubitemid 47232855)
61. Luo, X.; Budihardjo, I.; Zou, H.; Slaughter, C.; Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94, 481-490.
62. Kluck, R.M.; Bossy-Wetzel, E.; Green, D.R.; Newmeyer, D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275, 1132-1136. (Pubitemid 27097313)
63. Susin, S.A.; Lorenzo, H.K.; Zamzami, N.; Marzo, I.; Snow, B.E.; Brothers, G.M.; Mangion, J.; Jacotot, E.; Costantini, P.; Loeffler, M.; et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397, 441-446.
64. Du, C.; Fang, M.; Li, Y.; Li, L.; Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102, 33-42.
65. Li, L.Y.; Luo, X.; Wang, X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001, 412, 95-99. (Pubitemid 32851517)
66. Suzuki, Y.; Imai, Y.; Nakayama, H.; Takahashi, K.; Takio, K.; Takahashi, R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 2001, 8, 613-621. (Pubitemid 32946938)
67. Acehan, D.; Jiang, X.; Morgan, D.G.; Heuser, J.E.; Wang, X.; Akey, C.W. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell 2002, 9, 423-432. (Pubitemid 34195566)
68. Slee, E.A.; Harte, M.T.; Kluck, R.M.; Wolf, B.B.; Casiano, C.A.; Newmeyer, D.D.; Wang, H.G.; Reed, J.C.; Nicholson, D.W.; Alnemri, E.S.; Green, D.R.; Martin, S.J. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 1999, 144, 281-292. (Pubitemid 29066031)
69. Sakahira, H.; Enari, M.; Nagata, S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998, 391, 96-99. (Pubitemid 28079223)
70. Boulares, A.H.; Yakovlev, A.G.; Ivanova, V.; Stoica, B.A.; Wang, G.; Iyer, S.; Smulson, M. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J. Biol. Chem. 1999, 274, 22932-22940.
71. Hirata, H.; Takahashi, A.; Kobayashi, S.; Yonehara, S.; Sawai, H.; Okazaki, T.; Yamamoto, K.; Sasada, M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J. Exp. Med. 1998, 187, 587-600. (Pubitemid 28093361)
72. Kothakota, S.; Azuma, T.; Reinhard, C.; Klippel, A.; Tang, J.; Chu, K.; McGarry, T.J.; Kirschner, M.W.; Koths, K.; Kwiatkowski, D.J.; Williams, L.T. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997, 278, 294-298. (Pubitemid 27450877)
73. Takahashi, A.; Alnemri, E.S.; Lazebnik, Y.A.; Fernandes-Alnemri, T.; Litwack, G.; Moir, R.D.; Goldman, R.D.; Poirier, G.G.; Kaufmann, S.H.; Earnshaw, W.C. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA 1996, 93, 8395-8400.
74. Kumar, M.V.; Shirley, R.; Ma, Y.; Lewis, R.W. Role of genomics-based strategies in overcoming chemotherapeutic resistance. Curr. Pharm. Biotechnol. 2004, 5, 471-480. (Pubitemid 39317614)
75. Joza, N.; Susin, S.A.; Daugas, E.; Stanford, W.L.; Cho, S.K.; Li, C.Y.; Sasaki, T.; Elia, A.J.; Cheng, H.Y.; Ravagnan, L.; et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001, 410, 549-554.
76. Wang, X.; Wang, J.; Gengyo-Ando, K.; Gu, L.; Sun, C.L.; Yang, C.; Shi, Y.; Kobayashi, T.; Shi, Y.; Mitani, S.; Xie, X.S.; Xue, D. C. elegans mitochondrial factor WAH-1 promotes phosphatidylserine externalization in apoptotic cells through phospholipid scramblase SCRM-1. Nat. Cell Biol. 2007, 9, 541-549. (Pubitemid 46696535)
77. Studzinski, G.P. Overview of apoptosis. In Apoptosis: A Practical Approach; Oxford University Press: New York, NY, USA, 1999; p. 8.
78. Indran, I.R.; Tufo, G.; Pervaiz, S.; Brenner, C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim. Biophys. Acta 2011, 1807, 735-745.
79. Chen, L.; Gilkes, D.M.; Pan, Y.; Lane, W.S.; Chen, J. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage. EMBO J. 2005, 24, 3411-3422.
80. Vogelstein, B.; Lane, D.; Levine, A.J. Surfing the p53 network. Nature 2000, 408, 307-310.
81. Cheng, E.H.; Kirsch, D.G.; Clem, R.J.; Ravi, R.; Kastan, M.B.; Bedi, A.; Ueno, K.; Hardwick, J.M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997, 278, 1966-1968. (Pubitemid 28013242)
82. Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2008, 25, 35-94. (Pubitemid 351222507)
83. Frincke, J.M.; Faulkner, D.J. Antimicrobial metabolites of the sponge Reniera sp. J. Am. Chem. Soc. 1981, 104, 265-269.
84. Davidson, B.S. Renieramycin G, a new alkaloid from the sponge Xestospongia caycedoi. Tetrahedron Lett. 1992, 33, 3721-3724.
85. Suwanborirux, K.; Amnuoypol, S.; Plubrukarn, A.; Pummangura, S.; Kubo, A.; Tanaka, C.; Saito, N. Chemistry of renieramycins. Part 3. Isolation and structure of stabilized renieramycin type derivatives possessing antitumor activity from Thai sponge Xestospongia species, pretreated with potassium cyanide. J. Nat. Prod. 2003, 66, 1441-1446. (Pubitemid 37490391)
86. Pettit, G.R.; Knight, J.C.; Collins, J.C.; Herald, D.L.; Pettit, R.K.; Boyd, M.R.; Young, V.G. Antineoplastic agents 430. Isolation and structure of cribrostatins 3, 4, and 5 from the republic of maldives cribrochalina species. J. Nat. Prod. 2000, 63, 793-798. (Pubitemid 30452174)
87. Oku, N.; Matsunaga, S.; van Soest, R.W.; Fusetani, N. Renieramycin J, a highly cytotoxic tetrahydroisoquinoline alkaloid, from a marine sponge Neopetrosia sp. J. Nat. Prod. 2003, 66, 1136-1139.
88. Lane, J.W.; Estevez, A.; Mortara, K.; Callan, O.; Spencer, J.R.; Williams, R.M. Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G. Bioorg. Med. Chem. Lett. 2006, 16, 3180-3183.
89. Scott, J.D.; Williams, R.M. Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics. Chem. Rev. 2002, 102, 1669-1730.
90. Copp, B.R.; Fairchild, C.R.; Cornell, L.; Casazza, A.M.; Robinson, S.; Ireland, C.M. Naamidine A is an antagonist of the epidermal growth factor receptor and an in vivo active antitumor agent. J. Med. Chem. 1998, 41, 3909-3911. (Pubitemid 28447318)
91. Schroeder, F.C.; Kau, T.R.; Silver, P.A.; Clardy, J. The psammaplysenes, specific inhibitors of FOXO1a nuclear export. J. Nat. Prod. 2005, 68, 574-576. (Pubitemid 40586322)
92. McDonald, L.A.; Eldredge, G.S.; Barrows, L.R.; Ireland, C.M. Inhibition of topoisomerase II catalytic activity by pyridoacridine alkaloids from a Cystodytes sp. ascidian: a mechanism for the apparent intercalator-induced inhibition of topoisomerase II. J. Med. Chem. 1994, 37, 3819-3827. (Pubitemid 24346765)
93. Li, D.D.; Guo, J.F.; Huang, J.J.; Wang, L.L.; Deng, R.; Liu, J.N.; Feng, G.K.; Xiao, D.J.; Deng, S.Z.; Zhang, X.S.; Zhu, X.F. Rhabdastrellic acid-A induced autophagy-associated cell death through blocking Akt pathway in human cancer cells. PLoS One 2010, 5, e12176.
94. Li, J.; Xu, B.; Cui, J.; Deng, Z.; de Voogd, N.J.; Proksch, P.; Lin, W. Globostelletins A-I, cytotoxic isomalabaricane derivatives from the marine sponge Rhabdastrella globostellata. Bioorg. Med. Chem. 2010, 18, 4639-4647.
95. Zhang, W.H.; Che, C.T. Isomalabaricane-type nortriterpenoids and other constituents of the marine sponge Geodia japonica. J. Nat. Prod. 2001, 64, 1489-1492.
96. Tang, S.; Pei, Y.; Fu, H.; Deng, Z.; Li, J.; Proksch, P.; Lin, W. Jaspolides A-F, six new isomalabricane-type terpenoids from the sponge Jaspis sp. Chem. Pharm. Bull. (Tokyo) 2006, 54, 4-8.
97. Kondracki, M.L.; Guyot, M. Smenospongine: a cytotoxic and antimicrobial aminoquinone isolated from smenospongia. Tetrahedron Lett. 1987, 27, 5815-5818.
98. Aoki, S.; Kong, D.; Matsui, K.; Kobayashi, M. Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells. Anticancer Drugs 2004, 15, 363-369.
99. Kong, D.; Yamori, T.; Kobayashi, M.; Duan, H. Antiproliferative and antiangiogenic activities of smenospongine, a marine sponge sesquiterpene aminoquinone. Mar. Drugs 2011, 9, 154-161.
100. Kuroda, I.; Musman, M.; Ohtani, I.I.; Ichiba, T.; Tanaka, J.; Gravalos, D.G.; Higa, T. Pachastrissamine, a cytotoxic anhydrophytosphingosine from a marine sponge, Pachastrissa sp. J. Nat. Prod. 2002, 65, 1505-1506.
101. Makarieva, T.N.; Denisenko, V.A.; Stonik, V.A.; Milgrom, Y.M.; Rashkes, Y.W. Rhizochalin, a novel secondary metabolite of mixed biosynthesis from the sponge Rhizochalina incrustata. Tetrahedron Lett. 1989, 30, 6581-6584.
102. Jin, J.O.; Shastina, V.; Park, J.I.; Han, J.Y.; Makarieva, T.; Fedorov, S.; Rasskazov, V.; Stonik, V.; Kwak, J.Y. Differential induction of apoptosis of leukemic cells by rhizochalin, two headed sphingolipids from sponge and its derivatives. Biol. Pharm. Bull. 2009, 32, 955-962.
103. Pettit, G.R.; Cichacz, Z.A.; Gao, F.; Herald, C.L.; Boyd, M.R.; Schmidt, J.M.; Hooper, J.N.A. Isolation and Structure of Spongistatin-1. J. Org. Chem. 1993, 58, 1302-1304.
104. Bai, R.; Cichacz, Z.A.; Herald, C.L.; Pettit, G.R.; Hamel, E. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin. Mol. Pharmacol. 1993, 44, 757-766. (Pubitemid 23317288)
105. Schneiders, U.M.; Schyschka, L.; Rudy, A.; Vollmar, A.M. BH3-only proteins Mcl-1 and Bim as well as endonuclease G are targeted in spongistatin 1-induced apoptosis in breast cancer cells. Mol. Cancer Ther. 2009, 8, 2914-2925.
106. Rothmeier, A.S.; Schneiders, U.M.; Wiedmann, R.M.; Ischenko, I.; Bruns, C.J.; Rudy, A.; Zahler, S.; Vollmar, A.M. The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis. Int. J. Cancer 2010, 127, 1096-1105.
107. Meragelman, T.L.; Willis, R.H.; Woldemichael, G.M.; Heaton, A.; Murphy, P.T.; Snader, K.M.; Newman, D.J.; van Soest, R.; Boyd, M.R.; Cardellina, J.H., II; McKee, T.C. Candidaspongiolides, distinctive analogues of tedanolide from sponges of the genus Candidaspongia. J. Nat. Prod. 2007, 70, 1133-1138.
108. Pettit, G.R.; Xu, J.P.; Chapuis, J.C.; Pettit, R.K.; Tackett, L.P.; Doubek, D.L.; Hooper, J.N.; Schmidt, J.M. Antineoplastic agents. 520. Isolation and structure of irciniastatins A and B from the Indo-Pacific marine sponge Ircinia ramosa. J. Med. Chem. 2004, 47, 1149-1152. (Pubitemid 38229116)
109. Cichewicz, R.H.; Valeriote, F.A.; Crews, P. Psymberin, a potent sponge-derived cytotoxin from Psammocinia distantly related to the pederin family. Org. Lett. 2004, 6, 1951-1954.
110. Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2007, 24, 31-86. (Pubitemid 46238589)
111. Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2004, 21, 1-49. (Pubitemid 38260872)
112. Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2005, 22, 15-61. (Pubitemid 40346233)
113. Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2006, 23, 26-78.
114. Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2009, 26, 170-244.
115. Blunt, J.W.; Copp, B.R.; Munro, M.H.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2010, 27, 165-237.
116. Bao, B.; Sun, Q.; Yao, X.; Hong, J.; Lee, C.O.; Cho, H.Y.; Jung, J.H. Bisindole alkaloids of the topsentin and hamacanthin classes from a marine sponge Spongosorites sp. J. Nat. Prod. 2007, 70, 2-8.
117. Luo, X.; Li, F.; Hong, J.; Lee, C.O.; Sim, C.J.; Im, K.S.; Jung, J.H. Cytotoxic oxylipins from a marine sponge Topsentia sp. J. Nat. Prod. 2006, 69, 567-571. (Pubitemid 43798103)
118. Mansoor, T.A.; Lee, Y.M.; Hong, J.; Lee, C.O.; Im, K.S.; Jung, J.H. 5,6:8,9-diepoxy and other cytotoxic sterols from the marine sponge Homaxinella sp. J. Nat. Prod. 2006, 69, 131-134. (Pubitemid 43241770)
119. Zheng, L.; Yan, X.; Han, X.; Chen, H.; Lin, W.; Lee, F.S.; Wang, X. Identification of norharman as the cytotoxic compound produced by the sponge (Hymeniacidon perleve)-associated marine bacterium Pseudoalteromonas piscicida and its apoptotic effect on cancer cells. Biotechnol. Appl. Biochem. 2006, 44, 135-142. (Pubitemid 43844651)
120. Folmer, F.; Jaspars, M.; Dicato, M.; Diederich, M. Marine cytotoxins: callers for the various dances of death. Gastroenterol. Hepatol. Bed Bench 2009, 2, S34-S50.
121. Keyzers, R.A.; Daoust, J.; Davies-Coleman, M.T.; Van Soest, R.; Balgi, A.; Donohue, E.; Roberge, M.; Andersen, R.J. Autophagy-modulating aminosteroids isolated from the sponge Cliona celata. Org. Lett. 2008, 10, 2959-2962.
122. Vicencio, J.M.; Ortiz, C.; Criollo, A.; Jones, A.W.; Kepp, O.; Galluzzi, L.; Joza, N.; Vitale, I.; Morselli, E.; Tailler, M.; Castedo, M.; Maiuri, M.C.; Molgo, J.; Szabadkai, G.; Lavandero, S.; Kroemer, G. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ. 2009, 16, 1006-1017.
123. Andrews, P.A.; Howell, S.B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 1990, 2, 35-43. (Pubitemid 20218552)
124. Huang, G.S.; Lopez-Barcons, L.; Freeze, B.S.; Smith, A.B., III; Goldberg, G.L.; Horwitz, S.B.; McDaid, H.M. Potentiation of taxol efficacy and by discodermolide in ovarian carcinoma xenograft-bearing mice. Clin. Cancer Res. 2006, 12, 298-304. (Pubitemid 43166207)
125. Hadaschik, B.A.; Adomat, H.; Fazli, L.; Fradet, Y.; Andersen, R.J.; Gleave, M.E.; So, A.I. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin. Clin. Cancer Res. 2008, 14, 1510-1518. (Pubitemid 351413936)
126. Vahdat, L.T.; Pruitt, B.; Fabian, C.J.; Rivera, R.R.; Smith, D.A.; Tan-Chiu, E.; Wright, J.; Tan, A.R.; Dacosta, N.A.; Chuang, E.; et al. Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J. Clin. Oncol. 2009, 27, 2954-2961.
127. Wu, Y.C.; Zhu, J. Asymmetric total syntheses of (-)-renieramycin M and G and (-)-jorumycin using aziridine as a lynchpin. Org. Lett. 2009, 11, 5558-5561.
128. Aberle, N.S.; Lessene, G.; Watson, K.G. A concise total synthesis of naamidine A. Org. Lett. 2006, 8, 419-421. (Pubitemid 43241675)
129. Georgiades, S.N.; Clardy, J. Total synthesis of psammaplysenes A and B, naturally occurring inhibitors of FOXO1a nuclear export. Org. Lett. 2005, 7, 4091-4094. (Pubitemid 41361536)
130. Kotoku, N.; Tamada, N.; Hayashi, A.; Kobayashi, M. Synthesis of BC-ring model of globostellatic acid X methyl ester, an anti-angiogenic substance from marine sponge. Bioorg. Med. Chem. Lett. 2008, 18, 3532-3535. (Pubitemid 351787567)
131. Passiniemi, M.; Koskinen, A.M. Asymmetric synthesis of Pachastrissamine (Jaspine B) and its diastereomers viaeta(3)-allylpalladium intermediates. Org. Biomol. Chem. 2011, 9, 1774-1783.
132. Bhaket, P.; Morris, K.; Stauffer, C.S.; Datta, A. Total synthesis of cytotoxic anhydrophytosphingosine pachastrissamine (jaspine B). Org. Lett. 2005, 7, 875-876. (Pubitemid 40380248)
133. Crimmins, M.T.; Katz, J.D.; Washburn, D.G.; Allwein, S.P.; McAtee, L.F. Asymmetric total synthesis of spongistatins 1 and 2. J. Am. Chem. Soc. 2002, 124, 5661-5663. (Pubitemid 34533503)
134. Smith, A.B., III; Zhu, W.; Shirakami, S.; Sfouggatakis, C.; Doughty, V.A.; Bennett, C.S.; Sakamoto, Y. Total synthesis of (+)-spongistatin 1. An effective second-generation construction of an advanced EF Wittig salt, fragment union, and final elaboration. Org. Lett. 2003, 5, 761-764. (Pubitemid 37141097)
135. Huang, X.; Shao, N.; Palani, A.; Aslanian, R.; Buevich, A. The total synthesis of psymberin. Org. Lett. 2007, 9, 2597-2600.
136. Jiang, X.; Garcia-Fortanet, J.; De Brabander, J.K. Synthesis and complete stereochemical assignment of psymberin/irciniastatin A. J. Am. Chem. Soc. 2005, 127, 11254-11255.